These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30792609)

  • 1. Oral morphine protocol evaluation for the treatment of vaso-occlusive crisis in paediatric sickle cell patients.
    Paquin H; D Trottier E; Robitaille N; Pastore Y; Dore Bergeron MJ; Bailey B
    Paediatr Child Health; 2019 Feb; 24(1):e45-e50. PubMed ID: 30792609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a clinical protocol using intranasal fentanyl for treatment of vaso-occlusive crisis in sickle cell patients in the emergency department.
    Paquin H; Trottier ED; Pastore Y; Robitaille N; Dore Bergeron MJ; Bailey B
    Paediatr Child Health; 2020 Aug; 25(5):293-299. PubMed ID: 32765165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IF IM in a crisis: Intranasal fentanyl versus intravenous morphine in adult vaso-occlusive crisis.
    Assad O; Zamora R; Brown K; Melnitsky L; Moses J; Sherman V
    Am J Emerg Med; 2023 Feb; 64():86-89. PubMed ID: 36481614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel approach to reducing admissions for children with sickle cell disease in pain crisis through individualization and standardization in the emergency department.
    Schefft MR; Swaffar C; Newlin J; Noda C; Sisler I
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27274. PubMed ID: 29856534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An innovative short-stay health care model for treatment of uncomplicated vaso-occlusive crisis in adult sickle cell disease patients in Canada to reduce emergency department utilization.
    Binding A; Ward R; Phua C; Naessens V; O'Brien T; Bhatia S; Baranek H; Marani H; Mukerji G
    CJEM; 2019 Jan; 21(1):55-62. PubMed ID: 29039292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of the acute sickle cell vaso-occlusive crisis in the Emergency Department: a Brazilian method of switching from intravenous to oral morphine.
    Campos J; Lobo C; Queiroz AM; do Nascimento EM; Lima CB; Cardoso G; Ballas SK
    Eur J Haematol; 2014 Jul; 93(1):34-40. PubMed ID: 24571671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multimodal pain protocol for treatment of vaso-occlusive crisis in patients with sickle cell disease: Implementation and evaluation.
    Admiraal M; van Daalen J; Ritt MWJ; Dekker J; van Tuijn CFJ; Nur E; Hollmann MW; Hermanns H; Hermanides J; Biemond BJ
    Eur J Haematol; 2023 Sep; 111(3):382-390. PubMed ID: 37277324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electronic Health Record-Embedded Individualized Pain Plans for Emergency Department Treatment of Vaso-occlusive Episodes in Adults With Sickle Cell Disease: Protocol for a Preimplementation and Postimplementation Study.
    Luo L; King AA; Carroll Y; Baumann AA; Brambilla D; Carpenter CR; Colla J; Gibson RW; Gollan S; Hall G; Klesges L; Kutlar A; Lyon M; Melvin CL; Norell S; Mueller M; Potter MB; Richesson R; Richardson LD; Ryan G; Siewny L; Treadwell M; Zun L; Armstrong-Brown J; Cox L; Tanabe P
    JMIR Res Protoc; 2021 Apr; 10(4):e24818. PubMed ID: 33861209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study.
    Finkelstein Y; Schechter T; Garcia-Bournissen F; Kirby M; Nurmohamed L; Juurlink DN; Blanchette V; Koren G
    Clin Ther; 2007 Dec; 29(12):2738-43. PubMed ID: 18201591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of an ED High-Dose Opioid Protocol for Sickle Cell Disease Pain.
    Tanabe P; Martinovich Z; Buckley B; Schmelzer A; Paice JA
    J Emerg Nurs; 2015 May; 41(3):227-35. PubMed ID: 25241635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.
    van Beers EJ; van Tuijn CF; Nieuwkerk PT; Friederich PW; Vranken JH; Biemond BJ
    Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
    Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
    Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS
    Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial.
    Badaki-Makun O; Scott JP; Panepinto JA; Casper TC; Hillery CA; Dean JM; Brousseau DC;
    Pediatr Blood Cancer; 2014 Jun; 61(6):1049-54. PubMed ID: 24443249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral morphine protocol for sickle cell crisis pain.
    Conti C; Tso E; Browne B
    Md Med J; 1996 Jan; 45(1):33-5. PubMed ID: 8569458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.
    Hardwick WE; Givens TG; Monroe KW; King WD; Lawley D
    Pediatr Emerg Care; 1999 Jun; 15(3):179-82. PubMed ID: 10389953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department.
    García-Morin M; López-Sangüos C; Vázquez P; Alvárez T; Marañón R; Huerta J; Cela E
    Hemoglobin; 2016 Nov; 40(6):388-391. PubMed ID: 28361592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients.
    Bartolucci P; Habibi A; Khellaf M; Roudot-Thoraval F; Melica G; Lascaux AS; Moutereau S; Loric S; Wagner-Ballon O; Berkenou J; Santin A; Michel M; Renaud B; Lévy Y; Galactéros F; Godeau B
    EBioMedicine; 2016 Aug; 10():305-11. PubMed ID: 27412264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid Use in Vaso-Occlusive Crisis During Intravenous Opioid Drug Shortage.
    Katsivalis KV; Kosacz J; Austin Szwak J
    Hosp Pharm; 2022 Dec; 57(6):721-726. PubMed ID: 36340631
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of Individualized Pain Plans for Children With Sickle Cell Disease Admitted for Vaso-occlusive Crisis at Riley Hospital for Children.
    Arends AM; Perez A; Wilder C; Jacob SA
    J Pediatr Pharmacol Ther; 2022; 27(4):312-315. PubMed ID: 35558343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.